Table of Contents

doi : 10.1016/S0923-7534(25)00744-6

Volume 36, Issue 7, July 2025, Pages i-ii

خرید پکیج و مشاهده آنلاین مقاله

Editorial Board

doi : 10.1016/S0923-7534(25)00745-8

خرید پکیج و مشاهده آنلاین مقاله

The strengths and weaknesses of the final CAR-T cell-infused product are inherent to live drugs

doi : 10.1016/j.annonc.2025.04.008

خرید پکیج و مشاهده آنلاین مقاله

Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives

doi : 10.1016/j.annonc.2025.03.006

خرید پکیج و مشاهده آنلاین مقاله

Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis

doi : 10.1016/j.annonc.2025.03.019

خرید پکیج و مشاهده آنلاین مقاله

The impact of the immunological context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review

doi : 10.1016/j.annonc.2025.03.007

خرید پکیج و مشاهده آنلاین مقاله

Enrichment of CD7+CXCR3+ CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphoma

doi : 10.1016/j.annonc.2025.03.011

خرید پکیج و مشاهده آنلاین مقاله

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study

doi : 10.1016/j.annonc.2025.03.023

خرید پکیج و مشاهده آنلاین مقاله

Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

doi : 10.1016/j.annonc.2025.03.012

خرید پکیج و مشاهده آنلاین مقاله

Lung cancer detection by electronic nose analysis of exhaled breath: a multicentre prospective external validation study

doi : 10.1016/j.annonc.2025.03.013

خرید پکیج و مشاهده آنلاین مقاله

Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial

doi : 10.1016/j.annonc.2025.03.016

خرید پکیج و مشاهده آنلاین مقاله

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma

doi : 10.1016/j.annonc.2025.03.021

خرید پکیج و مشاهده آنلاین مقاله

Decaffeinated coffee consumption and risk of total and site-specific cancer

doi : 10.1016/j.annonc.2025.03.018

خرید پکیج و مشاهده آنلاین مقاله

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy☆

doi : 10.1016/j.annonc.2025.03.010

خرید پکیج و مشاهده آنلاین مقاله

Letter re: Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

doi : 10.1016/j.annonc.2025.03.014

خرید پکیج و مشاهده آنلاین مقاله

Response letter re: Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

doi : 10.1016/j.annonc.2025.03.015

خرید پکیج و مشاهده آنلاین مقاله

Letter Re: Lung cancer detection by electronic nose analysis of exhaled breath: a multi-center prospective external validation study

doi : 10.1016/j.annonc.2025.05.003

خرید پکیج و مشاهده آنلاین مقاله

Comments on the study of lung cancer detection by electronic nose analysis of exhaled breath

doi : 10.1016/j.annonc.2025.05.004

خرید پکیج و مشاهده آنلاین مقاله

Validation study of electronic nose detection for lung cancer

doi : 10.1016/j.annonc.2025.05.005

خرید پکیج و مشاهده آنلاین مقاله

Reply to Letter to the Editor “Lung cancer detection by electronic nose analysis of exhaled breath: a multi-center prospective external validation study� by Liu et al., G. Rocco, and Szarpak et al.

doi : 10.1016/j.annonc.2025.05.006

خرید پکیج و مشاهده آنلاین مقاله